Resting Metabolic Rate Testing in Bariatric Surgery Patients
Launched by BAYLOR RESEARCH INSTITUTE · Jul 17, 2017
Trial Information
Current as of November 06, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is checking whether a person’s resting metabolic rate (the number of calories they burn while at rest) measured before bariatric surgery can help predict how much weight they will lose after surgery, and whether this information could help choose the most suitable type of bariatric procedure. It is a single-group study (everyone gets the same tests) planned to include up to about 50 adults who are scheduled for their first bariatric surgery at the Baylor Weight Loss Surgery Center in Dallas.
If you participate, you’ll have metabolic testing before surgery and then again at 6 months and 1 year after surgery, with medical record follow-up planned for up to 5 years. The test with the ReeVue Indirect Calorimeter takes about 10 minutes and is done while you sit; you’ll wear a nose clip and a mouthpiece, and you should avoid stimulants or exercise on test day and not eat within 4 hours beforehand. The main goal is to measure percentage weight loss at 1 year, with a secondary goal of seeing how resting metabolic rate changes after surgery. This trial is overseen as a device-based study (not a drug trial) and is currently enrolling by invitation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients scheduled for a primary bariatric surgery
- • 18 years of age to no upper limit
About Baylor Research Institute
Baylor Research Institute (BRI) is a leading clinical research organization affiliated with Baylor Scott & White Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on translational medicine, BRI conducts a wide range of clinical trials across various therapeutic areas, including cardiovascular, oncology, and neurology. The institute is committed to fostering collaborative partnerships with academic institutions, industry leaders, and healthcare professionals to enhance the development of novel therapies and interventions. Through rigorous scientific methodology and ethical standards, Baylor Research Institute strives to contribute significantly to the advancement of healthcare and to provide patients with access to cutting-edge treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials